Literature DB >> 8704201

Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene.

M A Whitney1, G Royle, M J Low, M A Kelly, M K Axthelm, C Reifsteck, S Olson, R E Braun, M C Heinrich, R K Rathbun, G C Bagby, M Grompe.   

Abstract

Fanconi anemia (FA) is an autosomal recessive chromosome instability syndrome characterized by progressive bone marrow (BM) failure, skeletal defects, and increased susceptibility to malignancy. FA cells are hypersensitive to DNA cross-linking agents, oxygen and have cell cycle abnormalities. To develop an animal model of the disease we generated mice homozygous for a targeted deletion of exon 9 of the murine FA complementation group C gene (fac). Mutant mice had normal neonatal viability and gross morphology, but their cells had the expected chromosome breakage and DNA cross-linker sensitivity. Surprisingly, male and female mutant mice had reduced numbers of germ cells and females had markedly impaired fertility. No anemia was detectable in the peripheral blood during the first year of life, but the colony forming capacity of marrow progenitor cells was abnormal in vitro in mutant mice. Progenitor cells from fac knock-out mice were hypersensitive to interferon gamma. This previously unrecognized phenotype may form the basis for BM failure in human FA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704201

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  76 in total

1.  The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion.

Authors:  K Overturf; M Al-Dhalimy; M Finegold; M Grompe
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells.

Authors:  Patrizia Vinciguerra; Susana A Godinho; Kalindi Parmar; David Pellman; Alan D D'Andrea
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 3.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

4.  Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1.

Authors:  Kalindi Parmar; Jungmin Kim; Stephen M Sykes; Akiko Shimamura; Patricia Stuckert; Kaya Zhu; Abigail Hamilton; Mary Kathryn Deloach; Jeffery L Kutok; Koichi Akashi; D Gary Gilliland; Alan D'andrea
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

Review 5.  Molecular pathogenesis of Fanconi anemia.

Authors:  Natalie Collins; Gary M Kupfer
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 6.  Topics in pediatric leukemia--Fanconi's anemia: new insights.

Authors:  Noah Federman; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-04-06

Review 7.  Mouse models of Fanconi anemia.

Authors:  Kalindi Parmar; Alan D'Andrea; Laura J Niedernhofer
Journal:  Mutat Res       Date:  2009-04-10       Impact factor: 2.433

8.  Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1.

Authors:  Khadijeh Bijangi-Vishehsaraei; M Reza Saadatzadeh; Adam Werne; Kristina A Wilson McKenzie; Reuben Kapur; Hidenori Ichijo; Laura S Haneline
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

9.  Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis.

Authors:  Najoua Dendouga; Hui Gao; Dieder Moechars; Michel Janicot; Jorge Vialard; Clare H McGowan
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

10.  Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.

Authors:  Asmin Tulpule; M William Lensch; Justine D Miller; Karyn Austin; Alan D'Andrea; Thorsten M Schlaeger; Akiko Shimamura; George Q Daley
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.